Press Releases

eClinical Solutions elluminate® Platform Supports argenx to Enhance Data Oversight and Efficiency

Innovation allows for real-time data and operational insights to advance immunology breakthroughs

Baylor Genetics Connects with Genetic Counselors to Advance Answers in Rare and Undiagnosed Disease

Baylor Genetics, a leading diagnostic genomics partner offering a full spectrum of comprehensive genetic tests and diagnostic services, today announced it will be participating in two upcoming genetic counselor conferences.

Primerdesign Partners with Origin Sciences to Create Novel Rectal Mucosal Extraction Workflow

Robust DNA extraction supports earlier detection and diagnosis of colorectal cancer and other gastrointestinal diseases

Abselion Appoints Dale Gordon as Chair

Bioprocessing leader to drive continued commercial development and international expansion

CellCarta Secures Global Exclusivity for Biofidelity's Aspyre® Lung to Advance Targeted Lung Cancer Testing

CellCarta and Biofidelity today announce an expanded multi-year global strategic partnership, including exclusivity for Aspyre® Lung in clinical trial settings.

ClearNote Health Appoints Jeffrey Venstrom, MD, as Chief Medical Officer and Expands Leadership Team to Drive Clinical Adoption of Early Cancer Detection Tests

The team at ClearNote Health strengthened its leadership team with four key additions.

Babson Diagnostics Names Web Golinkin CEO

Babson Diagnostics has appointed Web Golinkin, formerly President and Chief Commercial Officer, as CEO and a member of the board to lead the company's next phase of commercial growth for its BetterWay™ blood testing system. Outgoing CEO David Stein, Ph.D., will transition to Executive Director to focus on strategic initiatives.

Baylor Genetics Enhances Whole Genome Sequencing Test with Optical Genome Mapping and Long‑Read Sequencing as Supplemental Technologies

Baylor Genetics, a leading diagnostic genomics partner offering a full spectrum of clinically relevant genetic testing, today announced enhancements to its Whole Genome Sequencing (WGS) test with the addition of optical genome mapping (OGM) and long‑read sequencing (LRS) as supplemental technologies. These advanced technologies — along with RNA sequencing — enable the company’s WGS test to go beyond standard sequencing approaches, providing a more precise view of a patient’s genome and delivering more answers to help guide patient care and outcomes.

Neuland to open commercial peptide facility as part of planned phased expansion

Abselion Establishes US Subsidiary in Cambridge, MA

Supports closer engagement with scientists in North America, to meet growing international adoption of its Amperia protein quantification platform

Certara Simcyp® Simulator Results Replace Ten Human Trials for Chronic Myeloid Leukemia (CML) Therapy asciminib

Biosimulation results highlight how model-informed approaches for drug development and regulatory decision-making save time and money.

Baylor Genetics to Highlight New Data and Product Innovations at 2026 ACMG Annual Clinical Genetics Meeting

Baylor Genetics, a leading diagnostic genomics partner offering a full spectrum of comprehensive genetic tests and diagnostic services, will showcase its latest scientific studies and product innovations at the 2026 American College of Medical Genetics and Genomics (ACMG) Annual Clinical Genetics Meeting on March 10-14 in Baltimore, MD. The company will highlight its innovative portfolio at booth #1017 and share a series of presentations and poster sessions throughout the meeting.

Proscia Earns Top Performance Score in the US, Sweeping 2026 KLAS Digital Pathology Ratings

Following Proscia’s Global Best in KLAS win in Europe, Concentriq is now the highest-rated digital pathology platform across multiple regions

Wisdom Bioscience Establishes Scientific Advisory Board to Advance Oral Cancer Diagnostics and Screening

• Drs Giulia Kennedy, Arnold Levine, John Sninsky, Martin Goldberg and Prof Tin Tin Su join SAB • Follows close of initial funding round with investment from Stephen Quake and Jay Flatley

ELRIG Appoints Dr Kelly Gray and Dr Elaine Duncan to its Board

• Strengthens leadership team to support next phase of growth as organisation evolves to meet needs of global drug discovery community • Drs Gray and Duncan to lead scientific programmes and early career initiatives, respectively

PrecisionLife and Ovation identify first potential genetic biomarkers to quantitatively predict GLP-1 efficacy response

PrecisionLife and Ovation today announced the results of the first phase of their collaboration to develop drug-response biomarkers to quantitively predict the efficacy, safety and tolerability of glucagon-like peptide-1 receptor agonist (GLP-1) therapies, and the extension of their partnership.

Healthcare Access Performance Leader BlockIt Rebrands as Alluvium Healthcare

Inceptua Group Appoints Healthcare Industry Leader Kurt Hilzinger as Chairman of the Board

Inceptua Group announces the appointment of Kurt J. Hilzinger as Chairman of the Board.

ClearNote Health’s Enhanced Avantect® Pancreatic Cancer Test Delivers Industry-Leading Early Detection Performance

ClearNote Health announced an enhanced version of its Avantect Pancreatic Cancer Test that delivers a higher overall cancer detection sensitivity of 82.6% and specificity of 97.5%.

Ambience Healthcare Expands “Chart Awareness” Across Its Intelligence Platform